Fundies.
English

Segment disclosures

Company overview

BIOVEST INTERNATIONAL INC

Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.

Revenue · Reported segment facts

4 dimension combinations 39 retained observations 11 reported periods

Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.

Cell Culture Services

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvti:CellCultureServicesMember
PeriodValueUnitFiledEvidence
2013-04-01 – 2013-06-30551000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2012-10-01 – 2013-06-30913000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2013-01-01 – 2013-03-31223000 USD20130515Open filing evidence
2012-10-01 – 2013-03-31362000 USD20130515Open filing evidence
2012-10-01 – 2012-12-31139000 USD20130215Open filing evidence
2011-10-01 – 2012-09-30839000 USD20121226Open filing evidence
2012-04-01 – 2012-06-30192000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2011-10-01 – 2012-06-30635000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2012-01-01 – 2012-03-31226000 USD20130515Open filing evidence
2011-10-01 – 2012-03-31443000 USD20130515Open filing evidence
2011-10-01 – 2011-12-31217000 USD20130215Open filing evidence
2010-10-01 – 2011-09-301272000 USD20121226Open filing evidence
2011-04-01 – 2011-06-30407000 USD20120814Open filing evidence
2010-10-01 – 2011-06-301069000 USD20120814Open filing evidence

Instrumentation Segment

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvti:InstrumentationSegmentMember
PeriodValueUnitFiledEvidence
2013-07-01 – 2013-09-301501000 USD2013-12-27 · 21:48:14.000ZOpen filing evidence
2012-10-01 – 2013-06-302559000 USD2013-12-27 · 21:48:14.000ZOpen filing evidence
2011-10-01 – 2012-09-303786000 USD2013-12-27 · 21:48:14.000ZOpen filing evidence

Instruments And Disposables

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvti:InstrumentsAndDisposablesMember
PeriodValueUnitFiledEvidence
2013-10-01 – 2013-12-31522000 USD20140214Open filing evidence
2013-04-01 – 2013-06-30644000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2012-10-01 – 2013-06-301646000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2013-01-01 – 2013-03-31592000 USD20130515Open filing evidence
2012-10-01 – 2013-03-311002000 USD20130515Open filing evidence
2012-10-01 – 2012-12-31549000 RestatedUSD20140214Open filing evidence
2011-10-01 – 2012-09-302947000 USD20121226Open filing evidence
2012-04-01 – 2012-06-30712000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2011-10-01 – 2012-06-302450000 RestatedUSD2013-08-14 · 19:01:19.000ZOpen filing evidence
2012-01-01 – 2012-03-31992000 USD20130515Open filing evidence
2011-10-01 – 2012-03-311738000 USD20130515Open filing evidence
2011-10-01 – 2011-12-31746000 USD20130215Open filing evidence
2010-10-01 – 2011-09-302365000 USD20121226Open filing evidence
2011-04-01 – 2011-06-30660000 USD20120814Open filing evidence
2010-10-01 – 2011-06-301811000 USD20120814Open filing evidence

Therapeutic Vaccine

Statement Business Segments

Source dimensions us-gaap:StatementBusinessSegmentsAxis=bvti:TherapeuticVaccineMember
PeriodValueUnitFiledEvidence
2012-10-01 – 2012-12-310 USD20130215Open filing evidence
2011-10-01 – 2012-09-30100000 USD2013-12-27 · 21:48:14.000ZOpen filing evidence
2011-10-01 – 2012-06-30100000 USD2013-08-14 · 19:01:19.000ZOpen filing evidence
2011-10-01 – 2012-03-31100000 USD20130515Open filing evidence
2011-10-01 – 2011-12-31100000 USD20130215Open filing evidence
2010-10-01 – 2011-09-30244000 USD20121226Open filing evidence
2010-10-01 – 2011-06-30244000 USD20120814Open filing evidence